TAK logo

TAK Other Income/Expenses (Net)

Latest reported-¥238.29B JPY
TAK TTM Other Income/Expenses (Net) · JPY (¥33.63B → -¥238.29B)
High-resolution chart · PNG

TAK other income/expenses (net) history

Trailing twelve months (TTM) · JPY. Each value covers four complete reported quarters.

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) Other Income/Expenses (Net) — Trailing twelve months (TTM) (JPY)
Period endingOther Income/Expenses (Net) (JPY)
-238,287,366,000
-233,524,366,000
-164,939,633,000
-147,692,000,000
-171,746,000,000
-167,535,000,000
-172,588,000,000
-175,707,000,000
-157,470,000,000
-160,865,000,000
-164,059,000,000
-160,242,000,000
-152,624,000,000
-114,049,000,000
-125,830,000,000
-130,284,000,000
-127,244,000,000
-158,273,000,000
-125,507,000,000
-114,561,000,000
-131,614,000,000
-143,034,000,000
-177,998,000,000
-173,322,000,000
-139,682,000,000
-102,439,000,000
-81,845,000,000
-118,041,000,000
-104,817,000,000
-110,073,000,000
-66,229,000,000
-34,399,000,000
-32,858,000,000
-24,584,000,000
-38,306,000,000
-6,824,000,000
-5,997,000,000
-12,520,000,000
-6,026,000,000
-8,936,000,000
-12,707,000,000
-10,289,000,000
-17,570,000,000
-21,033,000,000
-13,321,000,000
-16,183,000,000
-23,997,000,000
-4,071,000,000
7,475,000,000
4,137,000,000
8,559,000,000
-15,694,000,000
-172,888,000,000
-306,221,000,000
39,454,000,000
-84,043,000,000
-51,552,000,000
-12,549,000,000
-25,692,000,000
3,875,000,000
18,767,000,000
4,485,000,000
10,439,000,000
6,430,000,000
-14,852,000,000
-4,381,000,000
33,629,000,000
26,590,000,000
2,528,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.